Navigation Links
Investor Group Commends Jim Merselis for Joining Trinity Biotech's Board of Directors & Announces Conference Call Invitation
Date:2/12/2009

KANSAS CITY, Mo., Feb. 12 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB), an Irish based developer and manufacturer of diagnostic products, is delighted that Jim Merselis has joined the company's board of directors. In addition to expressing support for Mr. Merselis, the group has scheduled a conference call regarding important shareholder developments for 12:00 pm ET (9:00 am PT) on Tuesday, February 17, 2009.

All those interested in participating in the call should dial 888 300 5688 and reference Conference ID 85881585.

Commenting on the news, Mr. Reidy stated, "We are pleased Jim has agreed to serve, bringing the total of independent directors to two. While Jim's agreement to join as part of our broader effort is honorable, we continue our call to action for true board oversight and management accountability. We look forward to Jim remaining as part of our new board immediately following the pending action to remove and replace the current board."

Commenting on the campaign and pending conference call, Mr. Reidy stated, "Much progress has been made that we look forward to sharing with our fellow shareholders, and we remain committed to our goals to effect the changes needed to unlock shareholder value and provide the level of transparency we have continued to advocate."

Tom Reidy, 816-260-8476, tjreidy3@hotmail.com


'/>"/>
SOURCE KC Investor Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Champions Biotechnology, Inc.s Doug Burkett, PhD, to Present at BIO CEO & Investor Conference
2. Genaera to Present at BIO CEO & Investor Conference
3. Rigel to Present at BIO CEO & Investor Conference
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
5. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
6. VirtualScopics to Present at 11th Annual BIO CEO & Investor Conference
7. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
8. Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference
9. SuperGen to Present at BIO CEO & Investor Conference on February 10, 2009
10. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... Pompton Plains, NJ (PRWEB) May 25, 2013 ... Apple’s iPhone. The universal app version of Word Hunt ... Universal app versions of Concentration, Edge Match, Flash 2, Sudoku ... , The brain games’ gameplay and revolutionary lifetime brain ... and 4 inch displays. , “100 years of brain fitness ...
(Date:5/25/2013)... IBISWorld estimates that revenue for the Cell Therapy ... 28.7% to $1.0 billion in the five years to 2013, ... no new cell therapy products were introduced, according to IBISWorld ... period. In the years since, however, the Food and Drug ... to the industry's fast growth during the five years to ...
(Date:5/25/2013)... For college students, few events ... they are turning to prescription stimulants like Adderall ... more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . ... that students who pick up Adderall, “just to ... developing a physical and psychological dependency. While initially ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of ... of life". While a medical science, its scope enters into ... Its fundamental philosophy is that disease is the end result ... that in order to re-establish optimal health, we must discover ... a life style which brings us back into harmony. , ...
(Date:5/25/2013)... Arizona (PRWEB) May 25, 2013 The current ... Center, their parents, and the B2B staff all came together ... everyone enjoyed an array of Indian Cuisine, the residents got ... company, for helping them on their road to recovery, and ... the Drug and Alcohol center in 2010 after realizing the ...
Breaking Medicine News(10 mins):Health News:Acuity Games Apps Come to the iPhone 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Ayurveda Education Programs Offered by the California College of Ayurveda Include Panchakarma Certification, Practitioner Courses, and Body Therapy Classes 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
... Minneapolis for a one-day summit on Jan. 20, to ... (ICD) leads, which recently underwent a Class I FDA ... Mayo Clinic have organized the summit to develop a ... leads. Approximately 80,000 active patients have Riata or ...
... instance when the smaller sibling gets to call the shots ... has long been known to be a checkpoint in cell ... until their DNA has been fully replicated or repaired. Now ... of Technology have discovered a shorter form they,ve dubbed Chk1-S ...
... HealthDay Reporter , MONDAY, Jan. 2 (HealthDay News) ... at relieving neck pain in the long term than ... spinal manipulation therapy for neck pain also reported greater ... "We found that there are some viable ...
... Pirfenidone inhibits the development of inflammation and scarring (fibrosis) ... treatment of mild to moderate idiopathic pulmonary fibrosis (IPF) ... assessment in accordance with the Act on the Reform ... Institute for Quality and Efficiency in Health Care (IQWiG) ...
... (Boston) - The first-ever published whole-genome sequences of not just ... that both unusual and common genetic phenomena contribute to the ... the study -- led by researchers from the Boston University ... -- will be available to researchers around the world at ...
... State University researchers one working at a medieval burial ... East Lansing have shown how modern science can unlock ... first to confirm the existence of brucellosis, an infectious disease ... findings, which appear in the American Journal of Physical ...
Cached Medicine News:Health News:Summit seeks to inform electrophysiologists on Riata ICD recall 2Health News:Smaller sibling protein calls the shots in cell division 2Health News:Spinal Manipulation, Home Exercise May Ease Neck Pain 2Health News:Spinal Manipulation, Home Exercise May Ease Neck Pain 3Health News:Spinal Manipulation, Home Exercise May Ease Neck Pain 4Health News:Pirfenidone: Extent of added benefit assessed 2Health News:Pirfenidone: Extent of added benefit assessed 3Health News:Genetic predisposition to disease common in 2 supercentenarians: New study 2Health News:Scientists crack medieval bone code 2
(Date:5/24/2013)... CHESTERBROOK, Pa. , May 24, 2013  Auxilium ... that executive management will participate in the Deutsche Bank ... the Westin Boston Waterfront Hotel.  Mr. Adrian ... scheduled to present an overview of the Company and ... May 29, 2013.   (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ...
(Date:5/24/2013)... BEIJING , May 24, 2013  Sinovac ... leading provider of biopharmaceutical products in ... main operating subsidiary company of Sinovac, obtained the ... (GMP Certificate) from the China State and Food ... district bulk production plants, and its Changping filing ...
(Date:5/24/2013)... England and BOSTON , May 24, ... discovery and development company, is pleased to announce that it has ... to augment the Company,s business development capabilities in Japan ... more than 15 years of experience in business development, licensing and ... Sciences, Inc., Roche Pharma ( Japan ), Nippon Roche ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... MERCER ISLAND, Wash., Dec. 22, 2010 Renal Advantage and ... the third largest provider of dialysis services in the U.S., ... – terms of which were not disclosed – was completed ... serving more than 19,000 patients in 260 locations in 32 ...
... AstraZeneca (NYSE: AZN ... will discontinue the development of CERTRIAD™ (rosuvastatin calcium and fenofibric ... dyslipidemia. This means the co-development and license agreement with Abbott ... Complete Response Letter (CRL) for the CERTRIAD New Drug Application ...
Cached Medicine Technology:Renal Advantage and Liberty Dialysis Deal Completed 2Renal Advantage and Liberty Dialysis Deal Completed 3
... BioControl multichannel has the ... the single channel model.The ... all seven multichannel and ... cone modules. Both pipettes ...
... in a wide variety of applications. • Whole ... can be freely rotated against the handle to ... an optimum angle towards the microtiter plate. • ... of most common pipette tips, and provides a ...
... value!, Comfortable feel and less hand ... Finer control while pipetting with smooth, light ... with long, lever tip ejector , Completely ... the need for recalibration , Easy-to-read precision ...
... Designed with 96-well plates in ... useful for molecular biology applications: PCR* ... 96-well plates, etc. Used with Diamond ... system, this product will maximize performance ...
Medicine Products: